The term non-alcoholic fatty liver disease (NAFLD) appears unfitting both in adults and in
children. As obesity and metabolic syndrome play a relevant pathogenic role, an …

Nonalcoholic fatty liver disease (NAFLD) is increasing in prevalence in concert with the
global epidemic of obesity and is being diagnosed at increasingly younger ages. The …

Non-alcoholic fatty liver disease (NAFLD), more recently proposed as metabolic
(dysfunction)-associated fatty liver disease (MAFLD), is nowadays the most common chronic …

With the increasing prevalence of childhood obesity, nonalcoholic fatty liver disease
(NAFLD) has become the most common chronic pediatric liver disease in the developed …

Aim: Non‐alcoholic steatohepatitis (NASH) has been classified pathologically into type 1
(characterized by ballooning and perisinusoidal fibrosis) and type 2 (characterized by portal …

Objectives: The long-term prognosis of non-alcoholic fatty liver disease (NAFLD) in children
remains uncertain. We aimed at determining the long-term outcomes and survival of children …

Nonalcoholic fatty liver disease (NAFLD) is a significant health burden in adolescents and
young adults (AYAs) which has substantially risen in prevalence over the last decades. The …

Aim: To describe the prevalence, the clinical features and the risk factors in obese children
and adolescents with nonalcoholic fatty liver disease (NAFLD). Methods: Study comprising …

BACKGROUND & AIMS: Pediatric non-alcoholic fatty liver disease (NAFLD) may present
with a distinct histopathological pattern characterized by the presence of predominant portal …

Background The problem of obesity in children has grown considerably in recent years in
the United States as well as the rest of the world. This has resulted in a marked increase in …